Flash Finance

Titan Biotech Ltd524717Corporate

Specialty Chemicals Latest results: Jun 2026 14 quarters of data
Consolidated Standalone
₹407.15
MCap ₹1,681 Cr · P/E 49.6
Titan Biotech Ltd — Stock analysis & AI research Titan Biotech Ltd — Live exchange announcements
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹59 Cr
Sales · Jun 2026
+27.2% YoY
₹12 Cr
Operating Profit · Jun 2026
+42.9% YoY
21.1%
OPM % · Jun 2026
+12.2% YoY
₹11 Cr
Net Profit · Jun 2026
+58.3% YoY
₹2.63
EPS · Jun 2026
+58.4% YoY

📝 Titan Biotech Ltd — results explained

Quarter ended June 2026 (Q1 FY27)

Titan Biotech Ltd reported revenue of ₹59 crore for the quarter ended June 2026 (Q1 FY27), up 27.2% from ₹46 crore in the same quarter last year, and up 21.2% sequentially over the March 2026 quarter.

Net profit rose 58.3% year-on-year to ₹11 crore, from ₹7 crore. Earnings per share (EPS) came in at ₹2.63.

Operating profit stood at ₹12 crore — an operating margin (OPM) of 21.1%, compared with 18.8% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Titan Biotech Ltd posted revenue of ₹206 crore, a growth of 31.8% over FY25, with a net profit of ₹30 crore (up 38.7% year-on-year).

On a trailing-twelve-month (TTM) basis, revenue stands at ₹219 crore with a net profit of ₹34 crore.

Valuation snapshot

At the current price of ₹407.15, 524717 has a market capitalisation of ₹1,681 crore and a trailing P/E of about 49.6.

Within the Specialty Chemicals industry, it is the 23rd-largest of the 66 companies we track by market value.

Shareholding pattern

As of Jun 2026, promoters held 55.78%, domestic institutional investors (DIIs) 0.01%, public shareholders 44.21% of Titan Biotech Ltd.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹1,681 Cr
Current Price ?
₹407.1
P/E ?
49.63above ind
Industry P/E ?
29.60
P/B ?
9.29
P/S ?
7.68
P/FCF ?
80.06
Enterprise Value ?
₹1,687 Cr
EV/EBITDA ?
39.83
PEG ?
8.27
Earnings Yield ?
2.2%
Dividend Yield ?
0.09%
Profitability & Returns
Sales (TTM) ?
₹219 Cr
OPM ?
19.4%
Profit after tax (TTM) ?
₹34 Cr
EPS (TTM) ?
₹8.20
ROCE ?
23.0%
ROE ?
18.7%
ROA ?
15.8%
Growth
Sales — latest qtr ?
₹59 Cr
PAT — latest qtr ?
₹11 Cr
YoY qtr sales growth ?
27.2%
YoY qtr profit growth ?
58.3%
Sales growth (3y) ?
13%
Sales growth (5y) ?
8%
Profit growth (3y) ?
6%
Profit growth (5y) ?
0%
Financial Health
Debt ?
₹6 Cr
Debt to Equity ?
0.03
Interest Coverage ?
36.6
Current Ratio ?
N/A
Ownership
Promoter holding ?
55.78%
Change in promoter holding ?
0.00%
Pledged percentage ?
N/A
Market
Return 3 months ?
-5.0%
Return 6 months ?
2.7%

🗓️ Quarterly results (14 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best
Metric Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026 YoY % QoQ %
Sales 3735434640434038354654574959 +27.2% +21.2%
Operating Profit 789117885599111012 +42.9% +28.6%
Other Income 00100102111122 +151.8% -14.1%
Interest 00000000000000 -0.6% -17.2%
Depreciation 11111111111111 +18.9% +5.1%
Profit Before Tax 678106875589111013 +57.0% +23.9%
Net Profit 567756744789711 +58.3% +61.3%
EPS 1.201.491.581.741.211.551.621.060.981.661.882.071.632.63 +58.4% +61.3%
OPM % 18.6% 22.7% 20.1% 23.1% 17.7% 19.1% 19.5% 12.7% 13.0% 18.8% 17.2% 19.2% 19.9% 21.1% +12.2% +6.0%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric FY25 FY26 TTM YoY %
Sales ₹156 Cr ₹206 Cr ₹219 Cr +31.8%
Operating Profit ₹25 Cr ₹39 Cr ₹42 Cr +51.8%
OPM % 16.25% 18.73% 19.35% +15.3%
NPM % 13.77% 14.49% 15.48% +5.2%
Other Income ₹4 Cr ₹5 Cr ₹7 Cr +38.4%
Depreciation ₹4 Cr ₹5 Cr ₹5 Cr +18.2%
Interest ₹1 Cr ₹1 Cr ₹1 Cr +13.6%
EBIT ₹21 Cr ₹34 Cr ₹37 Cr +58.4%
PBT ₹24 Cr ₹38 Cr ₹43 Cr +56.7%
Tax — — ₹3 Cr —
Net Profit ₹22 Cr ₹30 Cr ₹34 Cr +38.7%
EPS ₹5.21 ₹7.24 ₹8.21 +39.0%
Material Cost — — ₹30 Cr —
Employee Cost — — ₹9 Cr —
Extraordinary Items — — — —

🏛️ Balance Sheet (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Equity Capital 8888 +0.0%
Reserves 102125145173 +19.3%
Borrowings 9836 +100.0%
Other Liabilities 16151927 +42.1%
Total Liabilities 135157175214 +22.3%
Fixed Assets 36525762 +8.8%
CWIP 13322 +0.0%
Investments 15283360 +81.8%
Other Assets 70748390 +8.4%
Total Assets 135157175214 +22.3%

💧 Cash Flow (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Cash from Operating Activity 21212030 +50.0%
Cash from Investing Activity -21-20-10-34 -240.0%
Cash from Financing Activity -2-3-80 +100.0%
Net Cash Flow -2-22-4 -300.0%
Free Cash Flow 8121221 +75.0%
CFO/OP 97%85%103%101% -1.9%

➗ Ratios (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Debtor Days 53424440 -9.1%
Inventory Days 179208242212 -12.4%
Days Payable 27152532 +28.0%
Cash Conversion Cycle 205234261220 -15.7%
Working Capital Days 109111130102 -21.5%
ROCE % 27%25%17%23% +35.3%

👥 Shareholding (latest 4 periods)

Metric Sep 2025Dec 2025Mar 2026Jun 2026 % Chg
Promoters 55.78%55.78%55.78%55.78% +0.0%
DIIs 0.03%0.03%0.03%0.01% -66.7%
Public 44.19%44.19%44.19%44.21% +0.0%
No. of Shareholders 16,04016,36717,45718,671 +7.0%

⚖️ Peer comparison

Industry: Specialty Chemicals · top 25 of 66 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 ASIANPAINT Asian Paints ₹2,472.50 237,025 49.8 37,152 4,798 19.5% 12.9% 5.1% 18.0% 18.1% 41.8%
2 SOLARINDS Solar Industries ₹22,290.00 201,702 101.3 11,351 2,051 27.3% 18.1% 30.3% 34.9% 70.3% 89.0%
3 PIDILITIND Pidilite Industries ₹1,566.90 159,492 60.2 15,399 2,676 24.5% 17.4% 11.1% 17.9% 21.3% 30.3%
4 BERGEPAINT Berger Paints ₹458.50 53,461 43.9 12,263 1,218 15.6% 9.9% 2.9% -4.7% 12.0% 28.6%
5 LINDEINDIA Linde India ₹6,250.00 53,303 97.6 2,654 546 34.4% 20.6% 1.8% 20.8% 21.6% -2.4%
6 FLUOROCHEM Gujarat Fluorochemicals ₹4,773.00 52,431 85.7 5,303 609 25.9% 11.5% 5.5% 5.1% 24.0% 19.0%
7 HSCL Himadri Speciality ₹664.25 33,516 41.6 4,974 805 20.2% 16.2% 1.0% 36.2% 28.0% 27.4%
8 ACUTAAS Acutaas Chemicals ₹3,163.20 25,897 67.1 1,462 387 37.2% 26.5% 33.0% 121.8% 59.1% 70.4%
9 AETHER Aether Industries ₹1,792.00 23,785 108.3 1,153 219 31.4% 19.0% 37.5% 38.8% 27.1% 8.0%
10 ATUL Atul ₹6,250.50 18,403 23.1 6,643 811 17.4% 12.2% 12.4% 38.2% 25.0% 91.8%
11 AARTIIND Aarti Industries ₹470.80 17,078 32.2 9,011 531 14.8% 5.9% 14.1% 26.6% 42.4% 260.5%
12 BASF BASF India ₹3,669.00 15,882 24.7 16,041 643 5.9% 4.0% -1.1% -12.4% 24.5% 163.0%
13 FINEORG Fine Organic ₹5,170.50 15,853 36.2 2,471 438 21.6% 17.7% 4.2% 1.5% 18.0% 18.0%
14 SPLPETRO Supreme Petrochem ₹820.50 15,429 32.0 5,644 482 12.9% 8.5% -11.4% -16.1% 22.1% 192.1%
15 KANSAINER Kansai Nerolac ₹188.79 15,269 25.4 8,264 589 12.1% 7.1% 2.9% -48.1% 9.8% 5.9%
16 PRIVISCL Privi Speciality ₹3,551.10 13,872 39.7 2,672 342 24.9% 12.8% 22.0% 71.1% 19.2% 44.2%
17 ANURAS Anupam Rasayan ₹1,153.90 13,137 74.3 2,535 225 22.2% 8.9% 64.5% 39.1% 34.8% 5.7%
18 VINATIORGA Vinati Organics ₹1,253.90 13,008 29.0 2,381 449 27.9% 18.8% -1.0% 9.6% 28.4% 4.5%
19 500123 Elantas Beck ₹13,869.00 10,995 61.9 937 177 23.2% 18.9% 11.1% 6.6% 34.8% 82.1%
20 PRASOLCHEM Prasol Chemicals ₹791.80 4,686 — — — — — — — 35.5% 154.3%
21 JUBLCPL Jubilant Agri ₹2,117.00 3,208 24.7 1,972 130 10.2% 6.6% — — 18.4% 4.8%
22 504092 Indokem ₹86.92 1,695 107.3 174 2 3.0% 1.3% -4.9% -41.1% 12.2% 52.9%
23 524717 Titan Biotech ₹576.80 1,681 70.3 219 34 19.4% 15.5% 31.8% 38.7% 27.2% 58.3%
24 PAUSHAKLTD Paushak ₹651.65 1,607 34.0 277 48 28.9% 17.2% 4.3% -18.4% 51.4% 50.1%
25 506532 Nitta Gelatin ₹1,664.40 1,511 14.6 591 103 24.3% 17.5% 12.0% 15.5% 1.3% 32.5%
❓ Frequently asked questions
What was Titan Biotech Ltd's revenue in Q1 FY27?
Titan Biotech Ltd reported revenue of ₹59 crore for the quarter ended June 2026 (Q1 FY27), up 27.2% from ₹46 crore in the same quarter last year, and up 21.2% sequentially over the March 2026 quarter.
What was Titan Biotech Ltd's net profit in Q1 FY27?
Net profit rose 58.3% year-on-year to ₹11 crore, from ₹7 crore. Earnings per share (EPS) came in at ₹2.63.
What is 524717's market capitalisation and P/E ratio?
At the current price of ₹407.15, 524717 has a market capitalisation of ₹1,681 crore and a trailing P/E of about 49.6.
Who owns Titan Biotech Ltd? (shareholding pattern)
As of Jun 2026, promoters held 55.78%, domestic institutional investors (DIIs) 0.01%, public shareholders 44.21% of Titan Biotech Ltd.
TTM ends 2026-06-30. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI